Skip Navigation

A Phase 1 Dose Escalation Trial of SYN125 Single Agent in Solid Tumors and in Combination with Fixed Dose SYN004 in Patients with Epithelial Cancers with EGFR Expressions

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04363242

Study #:
STUDY00145401

Start Date:
Mar 08, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04363242

View Complete Trial Details & Eligibility at ClinicalTrials.gov